SCM
MRNA icon

Shelton Capital Management’s Moderna MRNA Stock Holding History

Shelton Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9,493
Closed -$280K – 770
2025
Q4 		$280K Hold
9,493
– – 0.01% 519
2025
Q3 		$245K Hold
9,493
– – 0.01% 586
2025
Q2 		$262K Sell
9,493
-179
-2% -$4.71K 0.01% 542
2025
Q1 		$274K Sell
9,672
-2,000
-17% -$71K 0.01% 509
2024
Q4 		$485K Sell
11,672
-46,312
-80% -$2.21M 0.01% 358
2024
Q3 		$3.88M Buy
57,984
+900
+2% +$82.6K 0.1% 183
2024
Q2 		$6.78M Sell
57,084
-6,817
-11% -$863K 0.18% 120
2024
Q1 		$6.81M Buy
63,901
+2,479
+4% +$250K 0.19% 123
2023
Q4 		$6.11M Hold
61,422
– – 0.19% 125
2023
Q3 		$6.34M Buy
61,422
+10,760
+21% +$1.2M 0.23% 109
2023
Q2 		$6.16M Buy
50,662
+1,486
+3% +$198K 0.22% 103
2023
Q1 		$7.55M Buy
49,176
+18,872
+62% +$3.11M 0.31% 84
2022
Q4 		$5.44M Sell
30,304
-63,562
-68% -$10.4M 0.57% 37
2022
Q3 		$11.1M Sell
93,866
-280
-0.3% -$42.5K 0.53% 39
2022
Q2 		$13.4M Sell
94,146
-200
-0.2% -$28.6K 0.6% 31
2022
Q1 		$16.3M Sell
94,346
-200
-0.2% -$33.7K 0.6% 27
2021
Q4 		$24M Buy
94,546
+2,291
+2% +$670K 0.85% 18
2021
Q3 		$35.5M Sell
92,255
-13,246
-13% -$4.89M 1.39% 9
2021
Q2 		$24.8M Buy
105,501
+588
+0.6% +$105K 0.94% 17
2021
Q1 		$13.7M Buy
104,913
+3,571
+4% +$517K 0.48% 42
2020
Q4 		$10.6M Sell
101,342
-100
-0.1% -$10.1K 0.48% 39
2020
Q3 		$7.18M Buy
101,442
+34,342
+51% +$2.39M 0.3% 71
2020
Q2 		$4.31M Buy
67,100
+1,100
+2% +$60.2K 0.24% 83
2020
Q1 		$1.98M Buy
66,000
+35,000
+113% +$805K 0.14% 133
2019
Q4 		$606K Buy
+31,000
New +$550K 0.03% 307

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Shelton Capital Management's MRNA Position: Q1 2026 in Review

Shelton Capital Management sold out of Moderna (MRNA) in Q1 2026, closing a stake of 9,493 shares — an estimated $280K sold.

Shelton Capital Management first reported a position in MRNA in Q4 2019 and held it in 25 quarters. The position peaked at $35.5M in Q3 2021. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Shelton Capital Management reported no remaining Moderna position as of Q1 2026 after selling out during the quarter.
  • Shelton Capital Management sold 9,493 Moderna shares in Q1 2026, an estimated $280K.
  • Shelton Capital Management first reported a position in Moderna in Q4 2019 and held it in 25 quarters.
  • Shelton Capital Management's Moderna position peaked at $35.5M in Q3 2021.
  • 723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Shelton Capital Management's 13F filing for Q1 2026, filed 15 May 2026.